PGNY News and Press, Progyny Inc. From 02/02/22

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Amid heightened volatility from a new COVID-19 variant an...

NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Pete Anevski, Progyny’s Chief Executive Officer, will present at...

Progyny, Inc ( NASDAQ: PGNY ) shares have weakened more than 20% since November 05, even though the company reported strong third-quarter results. Management expects a further business acceleration Progyny is a company that specializes in fertility and family building benefi...

Progyny Inc. (NASDAQ:PGNY) traded at a new 52-week high today of $68.19. This new high was reached on below average trading volume as 149,000 shares traded hands, while the average 30-day volume is approximately 636,000 shares. Progyny Inc. (NASDAQ:PGNY) defies analysts with a current pr...

Image source: The Motley Fool. Progyny Inc (NASDAQ: PGNY) Q3 2021 Earnings Call Nov 4, 2021 , 4:45 p.m. ET Operator Continue reading For further details see: Progyny Inc (PGNY) Q3 2021 Earnings Call Transcript

Progyny, Inc. (PGNY) Q3 2021 Earnings Conference Call November 04, 2021 04:45 PM ET Company Participants James Hart - VP-Investor Relations David Schlanger - CEO Pete Anevski - President and COO Mark Livingston - CFO Conference Call Participants Anne Samuel - JPMorgan Michael Cherny - Bank of...

Record Number of New Clients and New Covered Lives Added for 2022 Reports Third Quarter Revenue of $122.3 Million; Expects Full Year 2021 Revenue Growth Between 47% and 49% Expects Full Year 2022 Revenue Growth of Approximately 50% David Schlanger to Become Executive Chairman and Pete...

Progyny (NASDAQ:PGNY) is scheduled to announce Q3 earnings results on Thursday, November 4th, after market close. The consensus EPS Estimate is $0.06 and the consensus Revenue Estimate is $125.52M (+26.9% Y/Y). Over the last 1 year, PGNY has beaten EPS estimates 75% of the time and has beaten...

NEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended September 30, 2021 after th...

The percentage of companies in the US that cover fertility benefits has grown significantly over the past five years. Progyny specializes in fertility benefits management and in a span of 5 years since launch has seen covered lives grow 25x, and employer clients expand from 5 to 180+....